STOCK TITAN
  1. Home
  2. Sec-filings
  3. ABVX
  4. [6-K] Abivax SA American Current Report (Foreign Issuer)

[6-K] Abivax SA American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ABVX logo
Abivax S.A.

NASDAQ:ABVX

ABVX Rankings

#1157 Ranked by Market Cap
N/A Ranked by Dividends

ABVX Latest News

Sep 8, 2025
Abivax Presents First Half 2025 Financial Results
Jul 28, 2025
Abivax Announces Closing of $747.5 Million Public Offering
Jul 25, 2025
Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M)
Jul 24, 2025
Abivax Announces Pricing of $650M (€554M) Public Offering of American Depositary Shares
Jul 24, 2025
Abivax announces trading resumption of its ordinary shares on Euronext Paris

ABVX Latest SEC Filings

Sep 8, 2025
[6-K] Abivax SA American Current Report (Foreign Issuer)
Aug 14, 2025
[SCHEDULE 13G/A] Abivax SA American SEC Filing
Jul 31, 2025
[SCHEDULE 13D/A] Abivax SA American SEC Filing
Jul 24, 2025
[424B5] Abivax SA American Prospectus Supplement (Debt Securities)
Jul 24, 2025
[6-K] Abivax SA American Current Report (Foreign Issuer)

ABVX Stock Data

6.80B
73.57M
41.79%
2.43%
Biotechnology
Healthcare
Link
France
Paris